Juan Sánchez‐Bursón

1.2k total citations
24 papers, 405 citations indexed

About

Juan Sánchez‐Bursón is a scholar working on Rheumatology, Immunology and Ophthalmology. According to data from OpenAlex, Juan Sánchez‐Bursón has authored 24 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 8 papers in Immunology and 5 papers in Ophthalmology. Recurrent topics in Juan Sánchez‐Bursón's work include Systemic Lupus Erythematosus Research (9 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Ocular Diseases and Behçet’s Syndrome (5 papers). Juan Sánchez‐Bursón is often cited by papers focused on Systemic Lupus Erythematosus Research (9 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Ocular Diseases and Behçet’s Syndrome (5 papers). Juan Sánchez‐Bursón collaborates with scholars based in Spain, United States and India. Juan Sánchez‐Bursón's co-authors include Miguel Á. González‐Gay, Hilde Carlier, Eun Bong Lee, Eswar Krishnan, Pentti A. Järvinen, Atul Deodhar, Éric Lespessailles, Xiaoqi Li, César Pacheco‐Tena and Denis Poddubnyy and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and Arthritis Research & Therapy.

In The Last Decade

Juan Sánchez‐Bursón

23 papers receiving 398 citations

Peers

Juan Sánchez‐Bursón
Puja Chitkara United States
M. E. C. Jeurissen Netherlands
Dhiman Basu United States
Puja Chitkara United States
Juan Sánchez‐Bursón
Citations per year, relative to Juan Sánchez‐Bursón Juan Sánchez‐Bursón (= 1×) peers Puja Chitkara

Countries citing papers authored by Juan Sánchez‐Bursón

Since Specialization
Citations

This map shows the geographic impact of Juan Sánchez‐Bursón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Sánchez‐Bursón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Sánchez‐Bursón more than expected).

Fields of papers citing papers by Juan Sánchez‐Bursón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Sánchez‐Bursón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Sánchez‐Bursón. The network helps show where Juan Sánchez‐Bursón may publish in the future.

Co-authorship network of co-authors of Juan Sánchez‐Bursón

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Sánchez‐Bursón. A scholar is included among the top collaborators of Juan Sánchez‐Bursón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Sánchez‐Bursón. Juan Sánchez‐Bursón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Genovese, Mark C., Juan Sánchez‐Bursón, Myungshin Oh, et al.. (2020). Comparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritis. Arthritis Research & Therapy. 22(1). 60–60. 15 indexed citations
3.
Yamanaka, Hisashi, Naoyuki Kamatani, Yoshiya Tanaka, et al.. (2019). A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis. Rheumatology and Therapy. 7(1). 149–163. 15 indexed citations
4.
Yamanaka, Hisashi, Naoyuki Kamatani, Yoshiya Tanaka, et al.. (2019). AB0416 A COMPARATIVE STUDY TO ASSESS THE EFFICACY, SAFETY, AND IMMUNOGENICITY OF YLB113 AND ETANERCEPT REFERENCE PRODUCT FOR THE TREATMENT OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 78. 1670–1670. 1 indexed citations
5.
Genovese, Mark C., Juan Sánchez‐Bursón, Myungshin Oh, et al.. (2019). AB0377 CLINICAL SIMILARITY OF ABP 710 WITH INFLIXIMAB (REFERENCE PRODUCT) IN SUBJECTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 78. 1648–1649. 1 indexed citations
6.
Juárez, Maria, Nieves Díaz, Geoffrey I. Johnston, et al.. (2019). AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME (PSS). Annals of the Rheumatic Diseases. 78. 1692–1693. 3 indexed citations
8.
Ortiz‐Fernández, Lourdes, Norberto Ortego‐Centeno, Rocío González-León, et al.. (2017). PTPN22 is not associated with Behçet's disease. Study spanning the complete gene region in the Spanish population and meta-analysis of the functional variant R620W.. PubMed. 34(6 Suppl 102). S41–S45. 3 indexed citations
9.
Montes‐Cano, Marco Antonio, José R. García‐Lozano, Lourdes Ortiz‐Fernández, et al.. (2014). Epistatic Interaction of ERAP1 and HLA-B in Behçet Disease: A Replication Study in the Spanish Population. PLoS ONE. 9(7). e102100–e102100. 24 indexed citations
10.
Montes‐Cano, Marco Antonio, Lourdes Ortiz‐Fernández, Norberto Ortego‐Centeno, et al.. (2013). HLA and non-HLA genes in Behçet’s disease: a multicentric study in the Spanish population. Arthritis Research & Therapy. 15(5). R145–R145. 39 indexed citations
11.
Casado, E., et al.. (2011). Defining High Risk of Osteoporotic Fracture. JCR Journal of Clinical Rheumatology. 17(5). S59–S66.
13.
Casado, E., et al.. (2011). Management of the Patient With a High Risk of Fracture in Clinical Practice. Results From a Survey of 174 Spanish Rheumatologists (OSTEOPAR Project). Reumatología Clínica (English Edition). 7(5). 305–313. 1 indexed citations
14.
García, R., Fernando Lozano, Juan Macı́as, et al.. (2003). Relationship Between Low Bone Mineral Density and Highly Active Antiretroviral Therapy Including Protease Inhibitors in HIV-Infected Patients. HIV Clinical Trials. 4(5). 337–346. 68 indexed citations
15.
Sánchez‐Bursón, Juan, et al.. (2002). Tubulointerstitial nephritis and uveitis syndrome in Southern Spain. Seminars in Arthritis and Rheumatism. 32(2). 125–129. 26 indexed citations
16.
Sánchez‐Bursón, Juan, et al.. (2000). Juvenile Neutrophilic Eccrine Hidradenitis: A Vasculitis-like Plantar Dermatosis. Clinical Rheumatology. 19(6). 481–483. 3 indexed citations
17.
Sánchez‐Bursón, Juan, et al.. (1999). Two cases of acute tubulointerstitial nephritis associated with panuveitis (TINU syndrome). PubMed. 26(1). 234–6. 10 indexed citations
18.
Sánchez‐Bursón, Juan, et al.. (1996). Thrombolytic Therapy in Pulmonary Embolism of Behçet’s Disease. Acta Haematologica. 96(3). 181–183. 12 indexed citations
19.
Sánchez‐Bursón, Juan, et al.. (1994). Pulmonary amyloidosis and unusual lung involvement in SLE. Clinical Rheumatology. 13(3). 525–527. 10 indexed citations
20.
Sánchez‐Bursón, Juan, et al.. (1992). [Sternoclavicular pneumococcal arthritis and multiple myeloma].. PubMed. 10(6). 379–80. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026